A Phase 2 Study to Evaluate the Efficacy and Safety of AMG531 in Aplastic Anemia

NCT02094417 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
35
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Kyowa Kirin Korea Co., Ltd.